| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.6 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |